Antoni Wiedlocha funded by the EEA Poland-Norway grants
Antoni Wiedlocha
The proposal "Novel targeted therapy based on dual warhead conjugates against FGFR dependent cancers", with senior scientist Antoni Wiedlocha at Department of Molecular Cell Biology, Institute for Cancer Research, as Norwegian partner and professor Jacek Otlewski at the University of Wroclaw as Polish parther, has been awarded funding from the EEA Poland-Norway grants under the "Applied Research" programme.
Links:
From the National Centre for Research and Development in Poland:
Published in Level 2 journals, first or last author from Oslo University Hospital.
Fjell AM, Rogeberg O, Sørensen Ø, Amlien IK, Bartrés-Faz D, Brandmaier AM, Cattaneo G, Düzel S, Grydeland H, Henson RN, Kühn S, Lindenberger U, Lyngstad TH, Mowinckel AM, Nyberg L, Pascual-Leone A, Solé-Padullés C, Sneve MH, Solana J, Strømstad M, Watne LO, Walhovd KB, Vidal-Piñeiro D(2025) Reevaluating the role of education on cognitive decline and brain aging in longitudinal cohorts across 33 Western countries Nat Med(in press) DOI 10.1038/s41591-025-03828-y, PubMed 40721513
Saatvedt O, Furunes H, Schubert PF, Fidje Ø, Molund M(2025) MRI Evaluation of Ligamentous Injury in Weightbearing-Stable Suprasyndesmotic Ankle Fractures: A Prospective Observational Study Foot Ankle Int, 10711007251352549(in press) DOI 10.1177/10711007251352549, PubMed 40721353
Bordin DL, Lefol Y, Largartos-Donate MJ, Montaldo NP, Rolseth V, Tekin NB, Lirussi L, Neurauter CG, Liu Y, Aman Y, Suganthan R, Sarno A, Zhang T, Alsøe L, Wang J, Bjørås M, Wong G, Nilsen H(2025) SMUG1 DNA glycosylase modulates reward behaviour through regulation of olfactory receptor gene expression Nucleic Acids Res, 53(14) DOI 10.1093/nar/gkaf722, PubMed 40716776